Enhanced down-regulation of ALCAM/CD166 in African-American Breast Cancer

被引：0
|
作者：
Fang Tan
Marina Mosunjac
Amy L Adams
Beverly Adade
Oleyad Taye
Yijuan Hu
Monica Rizzo
Solomon F Ofori-Acquah
机构：
[1] Emory University School of Medicine,Aflac Cancer Center and Blood Disorders Service, Department of Pediatrics
[2] Grady Memorial Hospital,Department of Pathology and Laboratory Medicine
[3] Emory University School of Medicine,Department of Biostatistics and Bioinformatics
[4] Rollins School of Public Health,Department of Surgery, Division of Surgical Oncology
[5] Emory University,undefined
[6] Emory University School of Medicine,undefined
[7] University of Pittsburgh,undefined
来源：
BMC Cancer | / 14卷
关键词：
ALCAM; African-American; Caucasian; Breast cancer;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] Enhanced down-regulation of ALCAM/CD166 in African-American Breast Cancer
    Tan, Fang
    Mosunjac, Marina
    Adams, Amy L.
    Adade, Beverly
    Taye, Oleyad
    Hu, Yijuan
    Rizzo, Monica
    Ofori-Acquah, Solomon F.
    BMC CANCER, 2014, 14
  • [2] ALCAM/CD166 protects breast cancer cells against apoptosis and autophagy
    Jezierska, Agnieszka
    Matysiak, Wojciech
    Motyl, Tomasz
    MEDICAL SCIENCE MONITOR, 2006, 12 (08): : BR263 - BR273
  • [3] Expression of ALCAM/CD166 and related proteins in breast cancer: tissue and cell lines
    不详
    BREAST, 2005, 14 : S17 - S17
  • [4] ALCAM (CD166) Expression and Serum Levels in Pancreatic Cancer
    Tachezy, Michael
    Zander, Hilke
    Marx, Andreas H.
    Stahl, Phillip R.
    Gebauer, Florian
    Izbicki, Jakob R.
    Bockhorn, Maximilian
    PLOS ONE, 2012, 7 (06):
  • [5] Predictive impact of activated leukocyte cell adhesion molecule (ALCAM/CD166) in breast cancer
    Ihnen, M.
    Mueller, V.
    Wirtz, R. M.
    Schroeder, C.
    Krenkel, S.
    Witzel, I.
    Lisboa, B. W.
    Jaenicke, F.
    Milde-Langosch, K.
    BREAST CANCER RESEARCH AND TREATMENT, 2008, 112 (03) : 419 - 427
  • [6] Predictive impact of activated leukocyte cell adhesion molecule (ALCAM/CD166) in breast cancer
    M. Ihnen
    V. Müller
    R. M. Wirtz
    C. Schröder
    S. Krenkel
    I. Witzel
    B. W. Lisboa
    F. Jänicke
    K. Milde-Langosch
    Breast Cancer Research and Treatment, 2008, 112 : 419 - 427
  • [7] ALCAM/CD166: A pleiotropic mediator of cell adhesion, stemness and cancer progression
    Ferragut, Fatima
    Vachetta, Vanina S.
    Troncoso, Maria F.
    Rabinovich, Gabriel A.
    Elola, Maria T.
    CYTOKINE & GROWTH FACTOR REVIEWS, 2021, 61 : 27 - 37
  • [8] Association between two polymorphisms of CD166/ALCAM gene and breast cancer risk in Chinese women
    Qinglong Li
    Feng Xu
    Breast Cancer Research and Treatment, 2011, 129
  • [9] Association between two polymorphisms of CD166/ALCAM gene and breast cancer risk in Chinese women
    Li, Qinglong
    Xu, Feng
    BREAST CANCER RESEARCH AND TREATMENT, 2011, 129 (02) : 645 - 646
  • [10] Functional polymorphisms in CD166/ALCAM gene associated with increased risk for breast cancer in a Chinese population
    Zhou, Ping
    Du, Liang-Feng
    Lv, Guo-Qiang
    Yu, Xian-Ming
    Gu, Yuan-Long
    Li, Jian-Ping
    Zhang, Chun
    BREAST CANCER RESEARCH AND TREATMENT, 2011, 128 (02) : 527 - 534
12345